Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Immunocompromised Host »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Immunocompetence < Immunocompromised Host < Immunoconjugates  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000309 (2019) Marine Ibranosyan [France] ; Laetitia Beraud [France] ; Hélène Lemaire [France] ; Anne-Gaëlle Ranc [France] ; Christophe Ginevra [France] ; Sophie Jarraud [France] ; Ghislaine Descours [France]The clinical presentation of Legionella arthritis reveals the mode of infection and the bacterial species: case report and literature review.
000446 (2019) Toshiyuki Watanabe [Japon] ; Jun Fukae [Japon] ; Shinji Fukaya [Japon] ; Norifumi Sawamukai [Japon] ; Masato Isobe [Japon] ; Megumi Matsuhashi [Japon] ; Masato Shimizu [Japon] ; Kazumasa Akikawa [Japon] ; Kazuhide Tanimura [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon]Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
000707 (2018) Sung Soo Ahn [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Jason Jungsik Song [Corée du Sud] ; Yong Beom Park [Corée du Sud] ; Jun Yong Park [Corée du Sud] ; Sang Won Lee [Corée du Sud]Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience.
000838 (2018) Shiang-Fen Huang [République populaire de Chine] ; Ming-Han Chen [République populaire de Chine] ; Fu-Der Wang [République populaire de Chine] ; Chang-Youh Tsai [République populaire de Chine] ; Chang-Phone Fung [République populaire de Chine] ; Wei-Juin Su [République populaire de Chine]Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
000857 (2018) K L Winthrop [États-Unis] ; X. Mariette [France] ; J T Silva [Espagne] ; E. Benamu [États-Unis] ; L H Calabrese [États-Unis] ; A. Dumusc [Suisse] ; J S Smolen [Autriche] ; J M Aguado [Espagne] ; M. Fernández-Ruiz [Espagne]ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
000952 (2017) M. Gaume [France] ; L. Marie-Hardy [France] ; F. Larousserie [France] ; M. Lavielle [France] ; C. Roux [France] ; P. Leclerc [France] ; A. Paugam [France] ; D. Archambeau [France] ; L. Eyrolle [France] ; R. Gauzit [France] ; O. Lortholary [France] ; P. Anract [France] ; L. Epelboin [France] ; D. Salmon [France][Histoplasma capsulatum bone and joint infection].
000A62 (2017) Le-Feng Chen [République populaire de Chine] ; Ying-Qian Mo [République populaire de Chine] ; Jun Jing [République populaire de Chine] ; Jian-Da Ma [République populaire de Chine] ; Dong-Hui Zheng [République populaire de Chine] ; Lie Dai [République populaire de Chine]Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation.
000B05 (2017) Nasir Saleem [États-Unis] ; Raya Saba [États-Unis] ; Srikanth Maddika [États-Unis] ; Mitchell Weinstein [États-Unis]Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
000C65 (2016) W. Opstelten [Pays-Bas] ; J W J. Bijlsma ; L B S. Gelinck ; C M J. Hielkema ; Th J M. Verheij ; W. Van Eden[Impaired immunity: risk groups and consequences for general practice].
000D69 (2016) Jun Nakamura [Japon] ; Takao Nagashima [Japon] ; Katsuya Nagatani [Japon] ; Taku Yoshio [Japon] ; Masahiro Iwamoto [Japon] ; Seiji Minota [Japon]Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
000F24 (2016) Sulaiman M. Al-Mayouf [Arabie saoudite] ; Abdullatif Alenazi [Arabie saoudite] ; Hind Aljasser [Arabie saoudite]Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.
001018 (2015) Ho Namkoong [Japon] ; Sadatomo Tasaka [Japon] ; Mitsuhiro Akiyama [Japon] ; Kazuma Yagi [Japon] ; Makoto Ishii [Japon] ; Katsuya Suzuki [Japon] ; Mitsutomo Kohno [Japon] ; Naoki Hasegawa [Japon] ; Tsutomu Takeuchi [Japon] ; Tomoko Betsuyaku [Japon]Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report.
001034 (2015) Huifeng Yun ; Fenglong Xie ; Elizabeth Delzell ; Lang Chen ; Emily B. Levitan ; James D. Lewis ; Kenneth G. Saag ; Timothy Beukelman ; Kevin Winthrop ; John W. Baddley ; Jeffrey R. CurtisRisks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.
001099 (2015) S. Nimmrich [Oman] ; G. HorneffIncidence of herpes zoster infections in juvenile idiopathic arthritis patients.
001109 (2015) Shunsuke Mori [Japon] ; Shigetoshi Fujiyama [Japon]Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations.
001117 (2015) Yoshiyuki Arinuma [Japon] ; Shinichi Nogi ; Yuichi Ishikawa ; Hisanori Nakayama ; Atsushi Hashimoto ; Akiko Komiya ; Kenji Minoguchi ; Ayako Horita ; Ikuo Saito ; Toshihiro Matsui ; Shigeto TohmaFatal complication of Legionella pneumophila pneumonia in a tocilizumab-treated rheumatoid arthritis patient.
001609 (2013) Hideaki Yamakawa [Japon] ; Noboru Takayanagi ; Takashi Ishiguro ; Tetsu Kanauchi ; Toshiko Hoshi ; Yutaka SugitaClinical investigation of nontuberculous mycobacterial lung disease in Japanese patients with rheumatoid arthritis receiving biologic therapy.
001623 (2013) Morgane Milin [France] ; Marie Acquitter ; Rozenn Le Berre ; Bruno Sassolas ; Valérie Devauchelle-Pensec ; Divi CornecBartonella henselae infection during tocilizumab therapy.
001728 (2012) Jun-Ichi Kawada [Japon] ; Naomi Iwata ; Yoshiro Kitagawa ; Hiroshi Kimura ; Yoshinori ItoProspective monitoring of Epstein-Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab.
001760 (2012) Shunsuke Mori [Japon] ; Yukitaka Ueki ; Naoyuki Hirakata ; Motohiro Oribe ; Toshihiko Hidaka ; Kazunori OishiImpact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis.
001761 (2012) Jatinder P. Ahluwalia [États-Unis]Immunotherapy in inflammatory bowel disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Immunocompromised Host" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Immunocompromised Host" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Immunocompromised Host
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021